PR Newswire
NEW YORK, Feb. 23, 2017
NEW YORK, Feb. 23, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Boston Scientific Corp. ("Boston Scientific" or the "Company") (NYSE: BSX). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/bsx.
The investigation concerns whether Boston Scientific and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.
On February 23, 2017, pre-market, Boston Scientific revealed a voluntary recall of its range of Lotus Valve heart devices, naming reports of an early release of a pin that connects the heart valve device to the delivery system. Boston Scientific said that it believes the problem is caused by "excess tension in the pin mechanism introduced during the manufacturing process" and anticipates bringing the products back on the market in 2017's fourth quarter. Following this news, Boston Scientific stock has dropped as much as $1.87 per share, or 7.43%, during intraday trading on February 23, 2017.
If you are aware of any facts relating to this investigation, or purchased shares of Boston Scientific, you can assist this investigation by visiting the firm's site: www.bgandg.com/bsx. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com
Kurzfristig positionieren in Boston Scientific | ||
ME98V9
| Ask: 0,18 | Hebel: 18,28 |
mit starkem Hebel |
Zum Produkt
| |
ME7VZ6
| Ask: 1,09 | Hebel: 4,82 |
mit moderatem Hebel |
Zum Produkt
| |
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-announces-investigation-of-boston-scientific-corp-bsx-300412660.html
SOURCE Bronstein, Gewirtz & Grossman, LLC
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.